Harbin Medisan Pharmaceutical Co., Ltd.

¥10.05As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002900Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR (9.04%)
Div yield —
ROE (12.60%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.30
PE TTM —
TSR TTM (28.82%)
Mkt cap ¥3.179B
ROIC (12.87%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥13
28.34%
(84.55%)
Hold 4|8|10|12|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.11
0.12
0.12
0.13
23.96%
24.02%
17.47%
19.08%
Revenue¥M
240.5
244.0
251.5
262.7
8.34%
7.86%
13.16%
13.89%
Peers (US$476.6M)
Cap (US$)
PE
483.6M
67.49x
473.0M
17.48x
Capital
TTM
5Y
10Y
Leveragex
0.813
0.113
0.123
EBIT/Intx
0.702
0.636
0.585
Own earn%
42.21
27.71
27.30
Sh yield%
53.11
50.21
52.29
Owners
Insiders/Inst%
5.14
24.84
Short interest%
2.96
SBC / revenue%
0.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
0–5
$1 testx
—
Incr. ROIC%
0